Kwang H. Ko
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Intranasal vaccines adjuvanted with Nexavant demonstrate robust protective efficacy by inducing both mucosal and systemic immunity in a murine model.
Journal: Frontiers in immunology
Published: November 13, 2025
Diagnostic cholangioscopy for surgical planning of extrahepatic cholangiocarcinoma.
Journal: Scientific reports
Published: August 11, 2024
Metal Stents for the Management of Massive Hemobilia in Patients with Hilum-Involving Cholangiocarcinoma Receiving Multi-Regimen Chemotherapy.
Journal: Gut and liver
Published: March 03, 2024
A vaccine platform targeting lung-resident memory CD4+ T-cells provides protection against heterosubtypic influenza infections in mice and ferrets.
Journal: Nature communications
Published: February 07, 2024
A novel defined TLR3 agonist as an effective vaccine adjuvant.
Journal: Frontiers in immunology
Published: October 20, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis.
Journal: Alimentary pharmacology & therapeutics
Published: August 03, 2022
Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma.
Journal: Surgery
Published: June 04, 2022
Optimal reproduction of a porcine benign biliary stricture model using endobiliary radiofrequency ablation.
Journal: Scientific reports
Published: February 11, 2022
Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial.
Journal: Gut and liver
Published: February 09, 2022
Last Updated: 09/26/2026